cigna glp-1 coverage Health insurer will stop covering weight loss drugs in its employee health plan CMS Extends Medicare's Short-Term Bridge

Tricia Rodriguez, Truveta senior applied research scientist & lead study author, explains the study findings concerning why GLP-1 users stop taking the drug.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), approved for diabetes and obesity, have shown promise in modulating reward-related brain pathways, suggesting potential benefits in the management of AUD

Injection-site reactions and worsening of pre-existing diabetic retinopathy are also relevant clinical concerns

While medications that reduce alcohol intake such as naltrexone and acamprosate have central nervous system action, disulfiram reduces alcohol intake through peripheral mechanisms

Discover what GLP-1 is, its role in the body and how GLP-1-based medications can help manage diabetes and weight

Find out how Ozempic affects your birth control.